Skip to content
The Galveston

Eli Lilly raises annual revenue forecast as obesity, diabetes drug demand stay strong

Aug 5 (Reuters) - Eli Lilly and Co raised its full-year revenue forecast on Wednesday, banking on sustained demand for its blockbuster GLP-1 weight-loss and diabetes drugs.

Sources and story details